Insider Selling: Adtalem Global Education (NYSE:CVSA) SVP Sells 9,615 Shares of Stock

Adtalem Global Education Inc. (NYSE:CVSA) SVP Douglas Beck sold 9,615 shares of the stock in a transaction dated Friday, May 8th. The stock was sold at an average price of $127.03, for a total transaction of $1,221,393.45. Following the sale, the senior vice president owned 38,159 shares of the company’s stock, valued at $4,847,337.77. This trade represents a 20.13% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Adtalem Global Education Trading Down 1.5%

Shares of CVSA traded down $1.96 during mid-day trading on Tuesday, hitting $128.28. 239,676 shares of the company’s stock were exchanged, compared to its average volume of 392,864. Adtalem Global Education Inc. has a fifty-two week low of $86.97 and a fifty-two week high of $156.26. The stock has a market cap of $4.37 billion, a price-to-earnings ratio of 19.98, a P/E/G ratio of 1.11 and a beta of 0.63. The company has a 50 day simple moving average of $111.84. The company has a debt-to-equity ratio of 0.36, a current ratio of 0.70 and a quick ratio of 0.70.

Adtalem Global Education (NYSE:CVSA) last announced its earnings results on Thursday, May 7th. The company reported $1.98 earnings per share for the quarter, topping the consensus estimate of $1.73 by $0.25. The business had revenue of $487.03 million during the quarter. Adtalem Global Education had a net margin of 12.26% and a return on equity of 20.19%. Adtalem Global Education’s quarterly revenue was up 4.5% on a year-over-year basis. During the same quarter last year, the company posted $1.92 EPS. Adtalem Global Education has set its FY 2026 guidance at 7.950-8.150 EPS. On average, equities research analysts forecast that Adtalem Global Education Inc. will post 8.05 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages recently commented on CVSA. Zacks Research downgraded shares of Adtalem Global Education from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, March 25th. Weiss Ratings began coverage on shares of Adtalem Global Education in a research report on Wednesday, February 25th. They issued a “hold (c+)” rating for the company. Truist Financial raised their price objective on shares of Adtalem Global Education from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday. Barrington Research restated an “outperform” rating and issued a $170.00 price objective on shares of Adtalem Global Education in a research report on Friday, April 17th. Finally, Wall Street Zen downgraded shares of Adtalem Global Education from a “buy” rating to a “hold” rating in a research report on Saturday. Two investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $155.00.

Adtalem Global Education Company Profile

Adtalem Global Education (NYSE: CVSA) is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.